Get startedLog in
    Picture of Altamira Therapeutics logo

    CYTOF — Altamira Therapeutics News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro CapNeutral
    All News

    Brief: Auris Medical Announces Positive Interim Results From AM-201 Phase 1B Study In Antipsychotic-Induced Weight Gain

    Picture of Altamira Therapeutics logoAltamira Therapeutics
    11/10/2019 13:38
    Oct 11 (Reuters) - Auris Medical Holding Ltd  EARS.O :
    * AURIS MEDICAL ANNOUNCES POSITIVE INTERIM RESULTS FROM
AM-201
PHASE 1B STUDY IN ANTIPSYCHOTIC-INDUCED WEIGHT GAIN
    * AURIS MEDICAL HOLDING LTD - ANTICIPATE DATA READ-OUT FROM
STUDY
TOWARDS END OF Q1 OF 2020

Source text for Eikon:  ID:nGNX3cDGKY 
Further company coverage:  EARS.O 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Altamira Therapeutics

    See all news